Start Ups Aim to Create Unlimited Fusion Energy within a Decade
In the style of Silicon Valley start ups, a group of engineers under the name Tri Alpha Energy have successfully raised $150 million in venture capital to build a fusion reactor.
What's the Latest?
A commercially-scaled fusion reactor could mean endless supplies of inexpensive energy--forever. That's a game changer if ever there was one. So in the style of Silicon Valley start ups, a group of engineers have successfully raised $150 million in venture capital to build a fusion reactor. Called Tri Alpha Energy, the group is developing a new technology that is smaller, simpler, and cheaper than the conventional fusion reactor known as "tokamak". Because the majority of US government funds earmarked for fusion research are already committed to a facility in France that is behind schedule and over budget, the task has fallen to Tri Alpha and about a dozen other companies attempting the same feat.
What's the Big Idea?
Several substantial hurdles currently face both domestic fusion companies and the larger, government-sponsored effort in France: engineers have yet to prove that fusion reactors "can achieve the billion-kelvin temperatures needed to burn the exotic fuel it wants to use [particularly as reactors are scaled up to commercial size], and must demonstrate a practical way to convert the energy output into electricity." Even the most sophisticated fusion reactors are planning to rely on steam-powered electricity generators, which run at 30-40 percent efficiency. Still, Tri Alpha predicts it will create commercial energy within a decade--that's well ahead of the 30-50 years typically quoted for tokamaks.
Read more at Nature
Photo credit: Shutterstock
The ability to speak clearly, succinctly, and powerfully is easier than you think
The ability to communicate effectively can make or break a person's assessment of your intelligence, competence, and authenticity.
Antimicrobial resistance is growing worldwide, rendering many "work horse" medicines ineffective. Without intervention, drug-resistant pathogens could lead to millions of deaths by 2050. Thankfully, companies like Pfizer are taking action.
- Antimicrobial-resistant pathogens are one of the largest threats to global health today.
- As we get older, our immune systems age, increasing our risk of life threatening infections. Without reliable antibiotics, life expectancy could decline for the first time in modern history.
- If antibiotics become ineffective, common infections could result in hospitalization or even death. Life-saving interventions like cancer treatments and organ transplantation would become more difficult, more often resulting in death. Routine procedures would become hard to perform.
- Without intervention, resistant pathogens could result in 10 million annual deaths by 2050.
- By taking a multi-faceted approach—inclusive of adherence to good stewardship, surveillance and responsible manufacturing practices, as well as an emphasis on prevention and treatment—companies like Pfizer are fighting to help curb the spread.
Journalism got a big wake up call in 2016. Can we be optimistic about the future of media?
- "[T]o have a democracy that thrives and actually that manages to stay alive at all, you need regular citizens being able to get good, solid information," says Craig Newmark.
- The only constructive way to deal with fake news? Support trustworthy media. In 2018, Newmark was announced as a major donor of two new media organizations, The City, which will report on New York City-area stories which may have otherwise gone unreported, and The Markup, which will report on technology.
- Greater transparency of fact-checking within media organizations could help confront and correct fake news. Organizations already exist to make media more trustworthy — are we using them? There's The Trust Project, International Fact-Checkers Network, and Tech & Check.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.